New Search

If you are not happy with the results below please do another search

Search
Generic filters

50 search results for:

4

GSK’s Challenging Week: Halted Study, Delayed FDA Decision and Departing Exec

GlaxoSmithKline discontinued a Phase II clinical trial evaluating an anti-LAG3 cell depleting monoclonal antibody aimed at treating ulcerative colitis licensed from Australia-based Immutep Limited following an interim assessment of an Independent Data Monitoring Committee.

5

Walmart expands vaccinations in boost to U.S. Covid-19 program

Walmart Inc. is preparing to offer Covid-19 vaccinations in seven more states, as well as in Chicago and Puerto Rico, expanding beyond the two states where the company’s pharmacists are offering inoculations.

7

Gap between Covid-19 shots may be stretched past recommended range in some cases

U.S. public health officials said a second Covid-19 shot could be administered as much as six weeks apart from the first one in situations where it was not possible to get a booster dose immediately.

8

Special Report: How U.S. CDC missed chances to spot COVID’s silent spread

Reuters found new evidence that the U.S. Centers for Disease Control and Prevention’s (CDC) response to the pandemic was marred by actions – or inaction – by the agency’s career scientists and frontline staff.